Benjamin McClellan, NP
Acute Care · Chattanooga, TNNPI 1629584461
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 301 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$1K
- Neurocrine Biosciences, Inc.$376
- Acadia Pharmaceuticals Inc$362
- Pfizer$280
- Lundbeck LLC$265
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,273100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 75 | $1,153 |
| AbbVie | 75 | $1,060 |
| Neurocrine Biosciences, Inc. | 18 | $376 |
| Acadia Pharmaceuticals Inc | 18 | $362 |
| Pfizer | 19 | $280 |
| Lundbeck LLC | 12 | $265 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $232 |
| Lilly USA, LLC | 10 | $203 |
| Inspire Medical Systems, Inc. | 9 | $200 |
| Axsome Therapeutics, Inc. | 8 | $143 |
| Harmony Biosciences LLC | 5 | $136 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $95 |
| Sanofi | 3 | $91 |
| Impel Pharmaceuticals Inc. | 4 | $85 |
| Neurelis, Inc. | 2 | $65 |
| Kyowa Kirin, Inc. | 2 | $48 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 1 | $36 |
| Boston Scientific | 1 | $34 |
| SK Life Science, Inc. | 1 | $33 |
| Sumitomo Pharma America, Inc. | 3 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $26 |
| MDD US Operations, LLC | 2 | $26 |
| EMD Serono, Inc. | 1 | $21 |
| Novartis | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| UCB, Inc. | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Almatica Pharma LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| 3b Medical, Inc. | 1 | $11 |
How this compares
$5,273 in reported general payments places this provider in the 90th percentile of 738 acute care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 13 | $211,380 |
| Gabapentin | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other acute care in Chattanooga
- Michelle GoochChattanooga$35K
- Lisa BrooksChattanooga$10K
- Laura CrowleyChattanooga$6K
- Tabetha EwtonChattanooga$5K
- Haley HoyNashville$368K
- Anne AlexandrovMemphis$110K
- Stephen MillerKnoxville$108K
- Shannon GraceNashville$57K
- Timothy BallardKnoxville$47K
- Kelsey MartinNashville$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.